the company has already been split....from an asx announcement on 24/07/14
"Admedus announced that it has increased its ownership in Admedus Vaccines, the platform vaccine development company led by Professor Ian Frazer"...note it is now Admedus Immunotherapies...
someone has already thought about it some time ago....so your question is irrelevant...
- Forums
- ASX - By Stock
- AVR
- More on cormatrix
More on cormatrix, page-10
Featured News
Add AVR (ASX) to my watchlist
(20min delay)
|
|||||
Last
$9.00 |
Change
0.200(2.27%) |
Mkt cap ! $190.2M |
Open | High | Low | Value | Volume |
$8.90 | $9.48 | $8.88 | $176.7K | 19.75K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 590 | $8.80 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$9.40 | 70 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 590 | 8.800 |
2 | 2067 | 8.680 |
1 | 260 | 8.510 |
1 | 300 | 8.500 |
1 | 2 | 8.420 |
Price($) | Vol. | No. |
---|---|---|
9.400 | 70 | 1 |
9.430 | 105 | 1 |
9.490 | 218 | 1 |
9.500 | 250 | 1 |
9.850 | 1000 | 1 |
Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |
The Watchlist
BTH
BIGTINCAN HOLDINGS LIMITED
David Keane, Co-Founder & CEO
David Keane
Co-Founder & CEO
Previous Video
Next Video
SPONSORED BY The Market Online